Search

everythinglearnresearchcommunity

for

Search:↓

Chemotherapy can cause skin side effects that affect patients' lives, but they can be managed to avoid interrupting cancer treatment.

Individualized treatment plans are crucial for children with alopecia areata, with promising options like JAK inhibitors showing significant hair regrowth.

Aging affects hair density and skin health, and Behcet's disease, a complex condition with no specific test, involves sores and systemic issues, treated with various medications.

Targeting drugs to hair follicles can treat skin conditions, but reaching deep follicle areas is hard and needs more research.

Hydroxychloroquine may help COVID-19 patients with lupus.

Doctors should diagnose hair loss by examining the patient and possibly doing tests, and then treat it based on the type, which may prevent permanent hair loss.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Hair follicles are important for drug delivery through the skin, but better methods are needed to understand and improve this process.

Combination therapies might work better for some vitiligo patients, but results vary.

A Japanese man with rare skin conditions improved with hydroxychloroquine treatment.

Certain drugs, especially those for eyes, bacterial infections, imaging tests, and skin conditions, are more likely to cause itching, with differences seen across gender, age, and weight.

The model successfully predicted new uses for existing drugs, like using certain hormonal and heart medications for respiratory and Parkinson's diseases, and a cancer drug for diabetes.

The document concludes that autoimmune skin disorders are treated with corticosteroids and immunosuppressive drugs.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

More research is needed to find the best treatment for dissecting cellulitis of the scalp.

About 8% of people with systemic lupus erythematosus have chronic scarring alopecia, with certain symptoms and positive antibodies increasing the risk, while immunosuppressants may lower it.

JAK inhibitors may soon be a safe and effective treatment for alopecia areata.

Patients with lupus nephritis and COVID-19 can improve with proper treatment.

Early diagnosis and aggressive treatment are crucial for Cicatricial Alopecia, and treatment effectiveness varies among patients.

A 5-year-old boy's skin condition improved with systemic valganciclovir after a cardiac transplant and immunosuppressive therapy.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

SLE patients in eastern Saudi Arabia have a generally good prognosis despite multi-organ involvement.

Some patients on immunosuppressants had a weaker immune response to the Sinovac-CoronaVac COVID-19 vaccine.

Teenage girls with Lupus often struggle with the disease's impact on their looks, which may lead them to change their medication without a doctor's advice.

Skin problems are common in Lupus patients and can indicate the disease's severity, requiring specific treatments and lifestyle changes.

Systemic lupus erythematosus is managed with lifestyle changes, symptomatic treatments, and careful use of medications to control symptoms and flares.

Lupus affects the skin in various ways, and proper skin examination is crucial for diagnosis and treatment.

Toxic epidermal necrolysis is a severe skin condition often caused by drugs, with complex treatment and a high risk of death, but survivors usually heal without scars.

The document concludes that treatments for female hair loss and excessive hair growth are temporary and not well-studied.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."